Literature DB >> 21338568

Impaired visual performance in patients with dry eye.

William H Ridder1, Alan Tomlinson, Jing-Feng Huang, Jim Li.   

Abstract

Patients with dry eye disease (DED) often complain about poor vision, which is not easily quantifiable. This review assesses the current understanding of clinical evaluations of visual function in patients with DED. Several noninvasive techniques for the assessment of visual performance have been utilized in patients with DED, and these are critically reviewed in relation to the visual symptoms experienced by these patients. It is clear that none of the current techniques is ideal, and there is not one appropriate, simple, clinical test that can be used for assessing visual impairment in patients with DED. Evidence from a comprehensive literature search combined with clinical experience have been used to identify which tests are currently of most benefit and to highlight the future development of a more specific clinical test for visual impairment in the dry eye patient.

Entities:  

Mesh:

Year:  2011        PMID: 21338568     DOI: 10.1016/s1542-0124(11)70009-x

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  12 in total

1.  Vision-Related Quality of Life in Patients with Ocular Graft-versus-Host Disease.

Authors:  Ujwala S Saboo; Francisco Amparo; Tulio B Abud; Debra A Schaumberg; Reza Dana
Journal:  Ophthalmology       Date:  2015-05-20       Impact factor: 12.079

2.  Prevalence, Severity, and Treatment Outcomes of Meibomian Gland Dysfunction in Patients With Dry Eye Symptoms at a Tertiary Care Center in South India.

Authors:  Jayanti Singh; Yamini Priya; Vivek Bhat
Journal:  Cureus       Date:  2022-06-07

3.  Dry Eye Disease: Impact on Quality of Life and Vision.

Authors:  Miki Uchino; Debra A Schaumberg
Journal:  Curr Ophthalmol Rep       Date:  2013-06

Review 4.  Use of the Controlled Adverse Environment (CAE) in Clinical Research: A Review.

Authors:  George W Ousler; David Rimmer; Lisa M Smith; Mark B Abelson
Journal:  Ophthalmol Ther       Date:  2017-09-27

Review 5.  Clinical utility of cyclosporine (CsA) ophthalmic emulsion 0.05% for symptomatic relief in people with chronic dry eye: a review of the literature.

Authors:  Michelle K Rhee; Francis S Mah
Journal:  Clin Ophthalmol       Date:  2017-06-21

6.  A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye.

Authors:  Yuli Park; Jong Suk Song; Chul Young Choi; Kyung Chul Yoon; Hyung Keun Lee; Hyun Seung Kim
Journal:  J Ocul Pharmacol Ther       Date:  2016-12-08       Impact factor: 2.671

7.  Topical administration of regorafenib eye drops: phase I dose-escalation study in healthy volunteers.

Authors:  Torsten Zimmermann; Joachim Höchel; Michael Becka; Michael K Boettger; Beate Rohde; Barbara Schug; Kathleen S Kunert; Frank Donath
Journal:  Br J Clin Pharmacol       Date:  2018-03-01       Impact factor: 4.335

8.  The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye.

Authors:  Karl G Stonecipher; Gail L Torkildsen; George W Ousler; Scot Morris; Linda Villanueva; David A Hollander
Journal:  Clin Ophthalmol       Date:  2016-05-13

9.  Vision-related quality of life and psychological status in Chinese women with Sjogren's syndrome dry eye: a case-control study.

Authors:  Yuqiu Zhang; Tong Lin; Alice Jiang; Naiqing Zhao; Lan Gong
Journal:  BMC Womens Health       Date:  2016-12-12       Impact factor: 2.809

10.  Assessment of visual function and Vision-related Quality of Life in female contact lens wearers with Dry Eye Syndrome.

Authors:  Kholoud A Bokhary; Noura Alomar
Journal:  Saudi J Ophthalmol       Date:  2018-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.